NXL
Nexalin Technology, Inc.Company Information
- Company Name
- Nexalin Technology, Inc.
- CIK
- CIK0001527352
- Category
- <br>Emerging growth company
- Ticker: Exchange
- NXL: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- NXL
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-03-12
- Last sale
- —
- Shares purchased (TTM)
- 41,619
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 849,541
- Shares outstanding
- 21,142,920
- Ownership
- 4.02%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -52.62%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | ||||||
| Short Term Investments | - | 2 | 3 | 4 | 5 | 1 | 3 | 5 | - | 2 | 2 | 4 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 2 | 3 | 4 | 5 | 6 | 3 | 4 | 5 | 1 | 3 | 3 | 4 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Intangible Assets Gross Excluding Goodwill | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Equity Method Investments | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets | - | - | - | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Assets | 3 | 4 | 5 | 5 | 7 | 3 | 4 | 5 | 2 | 3 | 4 | 4 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Liabilities Current | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | ||||||
| Liabilities | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | 0 | 0 | -0 | 0 | 0 | -0 | -0 | - | -0 | -0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Additional Paid In Capital | 99 | 98 | 97 | 95 | 94 | 89 | 88 | 87 | 81 | 80 | 80 | 79 | ||||||
| Retained Earnings Accumulated Deficit | -97 | -95 | -93 | -90 | -88 | -87 | -85 | -82 | -79 | -78 | -77 | -76 | ||||||
| Stockholders Equity | 2 | 3 | 4 | 5 | 6 | 2 | 4 | 5 | 1 | 2 | 3 | 3 | ||||||
Commitments And Contingencies Disclosure | ||||||||||||||||||
| Liabilities And Stockholders Equity | 3 | 4 | 5 | 5 | 7 | 3 | 4 | 5 | 2 | 3 | 4 | 4 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 0 | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 22 | 21 | 19 | 18 | 17 | 13 | 13 | 13 | 8 | 7 | 7 | 7 | ||||||
| Shares Outstanding | 22 | 21 | 19 | 18 | 17 | 13 | 13 | 13 | 8 | 7 | 7 | 7 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNexalin Technology, Inc. (NXL) — SEC Financial Statements & Analysis
Nexalin Technology, Inc. (NXL) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Nexalin Technology, Inc. trades on Nasdaq as: NXL. Nexalin Technology, Inc. (NXL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Nexalin Technology, Inc. carries a market cap of $209.31M, a P/E ratio of -23.29x, a P/B ratio of 137.76x, a P/S ratio of 963.90x, an enterprise value of $208.31M, and an EV/EBITDA multiple of -22.84x. On profitability, it posts a gross margin of 86.16%, an operating margin of -4202.54%, a net margin of -4139.38%, a Return on Equity (ROE) of -240.25%, a Return on Assets (ROA) of -187.89%, and a Return on Invested Capital (ROIC) of -301.47%. Per share, it reports EPS of $-0.43, diluted EPS of $-0.43, free cash flow per share of $-0.29, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.22% year-over-year, net income growth of 1.56% year-over-year, and EPS growth of -24.50% year-over-year. On the balance sheet, it maintains a current ratio of 1.25x, a quick ratio of 0.71x, working capital of $377.35K, a debt-to-equity ratio of 0.98x, a debt ratio of 0.49, an interest coverage ratio of -3496.56x, free cash flow of $-6.20M (TTM), and net debt of $-1.00M. Figures sourced from SEC EDGAR.
- Market Cap
- $209.31M
- P/E TTM
- -23.29x
- EPS TTM
- $-0.43
- P/B TTM
- 137.76x
- ROE TTM
- -240.25%
- ROA TTM
- -187.89%
- Debt To Equity
- 0.98x
- Free Cash Flow TTM
- $-6.20M
- Net Revenue TTM Growth 1Y
- 24.22%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Nexalin Technology, Inc. in?
Nexalin Technology, Inc. (NXL) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does NXL trade on?
Nexalin Technology, Inc. (NXL) trades on the Nasdaq.
Where is Nexalin Technology, Inc. incorporated?
Nexalin Technology, Inc. is incorporated in DE.
When was Nexalin Technology, Inc. (NXL)'s most recent SEC filing?
Nexalin Technology, Inc. (NXL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is NXL's market cap?
Nexalin Technology, Inc. (NXL) has a market capitalization of $209.31M as of 2026-06-30.
What is NXL's EPS (earnings per share)?
Nexalin Technology, Inc. (NXL)'s trailing twelve month EPS is $-0.43 as of 2026-06-30.
What is NXL's ROE (return on equity)?
Nexalin Technology, Inc. (NXL)'s trailing twelve month Return on Equity (ROE) is -240.25% as of 2026-06-30.
What is NXL's ROA (return on assets)?
Nexalin Technology, Inc. (NXL)'s trailing twelve month Return on Assets (ROA) is -187.89% as of 2026-06-30.
What is NXL's ROIC (return on invested capital)?
Nexalin Technology, Inc. (NXL)'s trailing twelve month Return on Invested Capital (ROIC) is -301.47% as of 2026-06-30.
What is NXL's EV/EBITDA?
Nexalin Technology, Inc. (NXL)'s trailing twelve month EV/EBITDA is -22.84x as of 2026-06-30.